$56M sweet spot round size
Most of their 20 investments are in rounds between $17M and $70M
2017
DermBiont, Inc. raised $28M on December 21, 2021
Investors: Viking Global Investors, toba capital, Olive Tree Capital, Civilization Ventures, Toba Capital and Nan Fung Life Sciences
Fountain Therapeutics raised $15M on November 18, 2021
Investors: K G Khosla compressors and Nan Fung Life Sciences
Engrail Therapeutics raised $32M on August 3, 2021
Investors: Nan Fung Life Sciences
Oculis S.A. raised $57M on May 4, 2021
Investors: Tekla Capital Management, VI Partners AG, BioVeda China Fund, Earlybird Venture Capital, Wille Finance and Nan Fung Life Sciences
Arctic Vision Ltd. raised $100M on March 9, 2021
Investors: Octagon Capital Advisors, Loyal Valley Capital, Tencent and Nan Fung Life Sciences
Encodia, Inc. raised $75M on January 27, 2021
Investors: ARCH Venture Partners, Tao Capital Partners, Decheng Capital, Biomatics Capital, Northpond Ventures, GV and Nan Fung Life Sciences
Arctic Vision Ltd. raised $32M on July 13, 2020
Investors: Nan Fung Life Sciences
Engrail Therapeutics raised $32M on June 18, 2020
Investors: Nan Fung Life Sciences
Fountain Therapeutics raised $6M on February 12, 2020
Investors: K G Khosla compressors and Nan Fung Life Sciences
Omniome raised $60M on January 9, 2020
Investors: Decheng Capital, Biomatics Capital, ARCH Venture Partners, Domain Associates and Nan Fung Life Sciences